Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;29(4-6):129-40.
doi: 10.1007/s10753-006-9008-9. Epub 2006 Nov 7.

Activatory properties of lysophosphatidic acid on human THP-1 cells

Affiliations

Activatory properties of lysophosphatidic acid on human THP-1 cells

F D'Aquilio et al. Inflammation. 2005 Dec.

Abstract

Excessive leukocyte proliferation and proinflammatory mediators release represent common phenomena in several chronic inflammatory diseases. Multiple evidences identify lysophosphatidic acid (LPA), a small lipid endowed with pleiotropic activities, as an important modulator of both proliferation and activation of different cell types involved in several inflammation-associated pathologies. However, its possible role on monocyte proinflammatory activation is not fully understood yet. Aim of the present study was to investigate LPA effects on THP-1 cells in terms of proliferation, reactive oxygen intermediates (ROI) production and release of arachidonic acid-derived inflammatory mediators. Actually, LPA significantly increased both DNA synthesis and ROI production as well as prostaglandin E(2) release and the upregulation of LPA(3) receptor expression. These findings identified LPA as both a growth factor and a triggering mediator of proinflammatory response in THP-1 cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cell Biochem. 2004 Aug 15;92(6):1104-14 - PubMed
    1. Cell Death Differ. 2006 Sep;13(9):1533-40 - PubMed
    1. Biochim Biophys Acta. 1994 Jul 21;1222(3):492-500 - PubMed
    1. Curr Vasc Pharmacol. 2003 Mar;1(1):85-98 - PubMed
    1. Mol Pharmacol. 2003 Oct;64(4):994-1005 - PubMed

MeSH terms

LinkOut - more resources